Kuros Biosciences (CHIX:KURNZ) Total Assets : CHF77.30 Mil (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Kuros Biosciences Total Assets?

Kuros Biosciences's Total Assets for the quarter that ended in Jun. 2024 was CHF77.30 Mil.

During the past 12 months, Kuros Biosciences's average Total Assets Growth Rate was 2.70% per year. During the past 3 years, the average Total Assets Growth Rate was -4.40% per year. During the past 5 years, the average Total Assets Growth Rate was -3.40% per year. During the past 10 years, the average Total Assets Growth Rate was 69.70% per year.

During the past 13 years, Kuros Biosciences's highest 3-Year average Total Assets Growth Rate was 547.20%. The lowest was -62.40%. And the median was -5.40%.

Total Assets is connected with ROA %. Kuros Biosciences's annualized ROA % for the quarter that ended in Jun. 2024 was -0.57%. Total Assets is also linked to Revenue through Asset Turnover. Kuros Biosciences's Asset Turnover for the quarter that ended in Jun. 2024 was 0.43.

Kuros Biosciences Total Assets Historical Data

The historical data trend for Kuros Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuros Biosciences Total Assets Chart

Kuros Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

87.85

94.36

91.34

82.95

71.46

Kuros Biosciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Assets	Get a 7-Day Free Trial															88.27	82.95	78.26	71.46	77.30

Kuros Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Kuros Biosciences's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	56.712	+	14.752
	=	71.46

Kuros Biosciences's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	60.175	+	17.128
	=	77.30

Kuros Biosciences (CHIX:KURNz) Total Assets Explanation

Total Assets is connected with ROA %.

Kuros Biosciences's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	-0.422	/	( (71.464	+	77.303)	/ 2 )
	=	-0.422	/	74.3835
	=	-0.57 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Kuros Biosciences's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	31.844	/	( (71.464	+	77.303)	/ 2 )
=	31.844	/	74.3835
=	0.43

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Kuros Biosciences Total Assets Related Terms

Thank you for viewing the detailed overview of Kuros Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Kuros Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (CHIX:KURNz) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

CSBTF:USA 0RHR:UK KURN:Switzerland

Address

Wagistrasse 25, Schlieren, Zurich, CHE, 8952

Website

https://www.kurosbio.com

Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.

Kuros Biosciences Headlines

No Headlines